# Development and Validation of HistoMX, a Gene-Expression Platform for Molecular Interpretation of Kidney Allograft Biopsies

> **NCT07700563** · — · COMPLETED · sponsor: **Paris Translational Research Center for Organ Transplantation** · enrollment: 2410 (actual)

## Conditions studied

- Kidney Transplant
- Rejection of Renal Transplant
- Antibody Mediated Rejection
- BK Virus Nephropathy
- T-Cell Mediated Rejection
- Chronic Kidney Disease (CKD) Stage 5
- Kidney Allograft Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07700563
- **Lead sponsor:** Paris Translational Research Center for Organ Transplantation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01-01
- **Primary completion:** 2026-05-15
- **Final completion:** 2026-05-15
- **Target enrollment:** 2410 (ACTUAL)
- **Last updated:** 2026-07-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700563, "Development and Validation of HistoMX, a Gene-Expression Platform for Molecular Interpretation of Kidney Allograft Biopsies". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07700563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*